Medicare Advantage contract

H1278 UnitedHealthcare

Local CCP · Parent: UnitedHealth Group, Inc.

⚠ Non-renewal ↓ Churn flag
Latest enrollment
189,741
2025-01
Year-over-year
-8.3%
contract book
National MA share
+0.3%
rank #42 of 936
Overall stars (latest)
★★★½ 3.5
summary rating

Enrollment trend · 5 years

052k103k155k207k20212022202320242025ReportedIncl. absorbed plans

Lineage-adjusted: history folds in H1821 (merged 2024), stitched through the CMS plan crosswalk so the combined footprint reads as one continuous line.

Star rating history

YearOverallPart CPart DΔ
2020
2021 3.5
2022 ★★★★ 4.0 4.0 4.0
2023 ★★★★ 4.0 4.0 4.0
2024 ★★★½ 3.5 3.5 3.5 -0.5

Premium

000112024202520260Median monthly premium ($)

Median monthly plan premium across this contract's plans, by year.

PlanYearMonthly premiumPart D premium
H1278-003 2026 $0.00 $0.00
H1278-005 2026 $0.00 $0.00
H1278-010 2026 $0.00 $0.00
H1278-013 2026 $0.00 $0.00
H1278-014 2026 $0.00 $0.00
H1278-015 2026 $0.00 $0.00
H1278-016 2026 $0.00 $0.00
H1278-018 2026 $nan $nan
H1278-020 2026 $30.00 $30.00
H1278-021 2026 $0.00 $0.00
H1278-024 2026 $0.00 $0.00
H1278-025 2026 $nan $nan

Showing 12 of 19 plans under this contract.

Premium analytics

Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.

Measure-level star movers

2023 → 2024

17 measures moved — 3 ↑ · 14 ↓

  • C23 Rating of Health Plan 5★ → 2★
  • C17 Transitions of Care 5★ → 2★
  • D06 Getting Needed Prescription Drugs 4★ → 2★
  • C11 Controlling High Blood Pressure 5★ → 3★
  • C26 Members Choosing to Leave the Plan 5★ → 3★
  • C25 Complaints about the Health Plan 3★ → 4★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and projected next-year exposure. Talk to us →

County enrollment

0 counties
StateCountyEnrollment
🔒

Want a custom analysis on this?

Talk to us →

County market share vs. competitors

service-area overlap

Head-to-head share by county against named competitors, with expansion whitespace and defended turf.

🔒

Want a custom analysis on this?

Talk to us →